Endothelial Glycocalyx and Cardiomyocyte Damage Is Prevented by Recombinant Syndecan-1 in Acute Myocardial Infarction

The authors investigated the effects of acute myocardial infarction on endothelial nanomechanics and function and the use of exogenous recombinant syndecan-1, a major component of the endothelial glycocalyx, as recovering agent.